Literature DB >> 22355524

SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure.

Andreas Walker1, Claudia Skamel, Michael Nassal.   

Abstract

Nanoparticles displaying native proteins are attractive for many applications, including vaccinology. Virus-based nanoparticles are easily tailored by genetic means, commonly by inserting heterologous sequences into surface-exposed loops. The strategy works well with short peptides but is incompatible with the structures of most native proteins, except those with closely juxtaposed termini. Here we overcome this constraint by splitting the capsid protein of hepatitis B virus, one of the most advanced and most immunogenic display platforms, inside the insertion loop (SplitCore). The split parts, coreN and coreC, efficiently form capsid-like particles (CLPs) in E. coli and so do numerous fusions to coreN and/or coreC of differently structured proteins, including human disease related antigens of >300 amino acids in length. These CLPs induced high-titer antibodies, including neutralizing ones, in mice. The concept was easily expanded to triple-layer CLPs carrying reporter plus targeting domains, and should be applicable to protein-based nanoparticle design in general.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22355524      PMCID: PMC3216493          DOI: 10.1038/srep00005

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  59 in total

1.  The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface.

Authors:  Norman R Watts; James F Conway; Naiqian Cheng; Stephen J Stahl; David M Belnap; Alasdair C Steven; Paul T Wingfield
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

2.  Diversity of core antigen epitopes of hepatitis B virus.

Authors:  D M Belnap; N R Watts; J F Conway; N Cheng; S J Stahl; P T Wingfield; A C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

3.  Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection.

Authors:  Claudia Skamel; Martin Ploss; Bettina Böttcher; Thomas Stehle; Reinhard Wallich; Markus M Simon; Michael Nassal
Journal:  J Biol Chem       Date:  2006-04-18       Impact factor: 5.157

4.  Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus.

Authors:  K M Taylor; T Lin; C Porta; A G Mosser; H A Giesing; G P Lomonossoff; J E Johnson
Journal:  J Mol Recognit       Date:  2000 Mar-Apr       Impact factor: 2.137

5.  Packaging of up to 240 subunits of a 17 kDa nuclease into the interior of recombinant hepatitis B virus capsids.

Authors:  G Beterams; B Böttcher; M Nassal
Journal:  FEBS Lett       Date:  2000-09-15       Impact factor: 4.124

6.  Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.

Authors:  B G Stiles; A R Garza; R G Ulrich; J W Boles
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 7.  HBV core particles as a carrier for B cell/T cell epitopes.

Authors:  P Pumpens; E Grens
Journal:  Intervirology       Date:  2001       Impact factor: 1.763

8.  Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.

Authors:  W Ding; X Huang; X Yang; J J Dunn; B J Luft; S Koide; C L Lawson
Journal:  J Mol Biol       Date:  2000-10-06       Impact factor: 5.469

9.  Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding.

Authors:  J F Conway; N R Watts; D M Belnap; N Cheng; S J Stahl; P T Wingfield; A C Steven
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 10.  Elucidation of Lyme arthritis.

Authors:  Allen C Steere; Lisa Glickstein
Journal:  Nat Rev Immunol       Date:  2004-02       Impact factor: 53.106

View more
  32 in total

1.  SplitCore Technology Allows Efficient Production of Virus-Like Particles Presenting a Receptor-Contacting Epitope of Human IgE.

Authors:  A Zh Baltabekova; Zh S Shagyrova; A S Kamzina; M Voykov; Ye Zhiyenbay; E M Ramanculov; A V Shustov
Journal:  Mol Biotechnol       Date:  2015-08       Impact factor: 2.695

Review 2.  The Structural Biology of Hepatitis B Virus: Form and Function.

Authors:  Balasubramanian Venkatakrishnan; Adam Zlotnick
Journal:  Annu Rev Virol       Date:  2016-08-01       Impact factor: 10.431

3.  Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes.

Authors:  Jasmin Federizon; Amber Frye; Wei-Chiao Huang; Thomas M Hart; Xuedan He; Christopher Beltran; Ashley L Marcinkiewicz; Iain L Mainprize; Melanie K B Wills; Yi-Pin Lin; Jonathan F Lovell
Journal:  Vaccine       Date:  2019-11-11       Impact factor: 3.641

4.  Molecular determinants of large cargo transport into the nucleus.

Authors:  Giulia Paci; Tiantian Zheng; Joana Caria; Anton Zilman; Edward A Lemke
Journal:  Elife       Date:  2020-07-21       Impact factor: 8.140

5.  Protein Nanoparticles as Multifunctional Biocatalysts and Health Assessment Sensors.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Emily Hartzell; J Vincent Price; Wilfred Chen
Journal:  Curr Opin Chem Eng       Date:  2016-09-04       Impact factor: 5.163

6.  Structures of hepatitis B virus cores presenting a model epitope and their complexes with antibodies.

Authors:  A M Roseman; O Borschukova; J A Berriman; S A Wynne; P Pumpens; R A Crowther
Journal:  J Mol Biol       Date:  2012-06-28       Impact factor: 5.469

7.  Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins.

Authors:  Hadrien Peyret; Annick Gehin; Eva C Thuenemann; Donatienne Blond; Aadil El Turabi; Lucy Beales; Dean Clarke; Robert J C Gilbert; Elizabeth E Fry; David I Stuart; Kris Holmes; Nicola J Stonehouse; Mike Whelan; William Rosenberg; George P Lomonossoff; David J Rowlands
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

8.  Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential.

Authors:  Philipp Kolb; Reinhard Wallich; Michael Nassal
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

9.  Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus.

Authors:  Xin Cheng; Weiwei Guan; Shuo Sun; Baosheng Li; Haijun Li; Fubiao Kang; Jiwen Kang; Dongliang Yang; Michael Nassal; Dianxing Sun
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

10.  Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.

Authors:  Milena Lange; Melanie Fiedler; Dorothea Bankwitz; William Osburn; Sergei Viazov; Olena Brovko; Abdel-Rahman Zekri; Yury Khudyakov; Michael Nassal; Paul Pumpens; Thomas Pietschmann; Jörg Timm; Michael Roggendorf; Andreas Walker
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.